Results 101 to 110 of about 315,361 (205)

Evaluation of the In Vitro Capacity of Anti-Human Cytomegalovirus Antibodies to Initiate Antibody-Dependent Cell Cytotoxicity. [PDF]

Microorganisms
d'Angelo P, Zavaglio F, Gabanti E, Zelini P, Fornara C, Bernuzzi S, Spinillo A, Lilleri D, Baldanti F.   +8 more
europepmc   +1 more source

Cell mediated cytotoxicity against Sendai virus infected cells [PDF]

, 1976
Bevan, Bhatnagar, Brunner, Gardner, Gardner, Gordon, Julius, Kedar, Kieling, Koszinowski, Koszinowski, Koszinowski, Lagrange, Lesley, Mcfarland, Pfizenmaier, Rehn, Reif, Schmitt-Verhulst, Shearer, Wagner, Zinkernagel   +21 more
core   +1 more source

A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death. [PDF]

Front Oncol
Choi AY, Kim D, Lee C, Ahn JS, Yang DH, Lee D, Kim JY.   +6 more
europepmc   +1 more source

FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy. [PDF]

Cancer Cell Int
Marei HE, Pozzoli G, Caratelli S, Cenciarelli C.   +3 more
europepmc   +1 more source

Targeted photodynamic therapy of breast cancer cells using antibody–phthalocyanine–gold nanoparticle conjugates [PDF]

, 2011
Cook, MJ, Edwards, DR, Moreno, M, Russell, DA, Stuchinskaya, T   +4 more
core   +1 more source

An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cells. [PDF]

Cancer Immunol Immunother
Sato Y, Goto K, Yagishita S, Miyata K, Uesugi N, Torisawa YS, Naritomi Y, Takahashi R, Sho R, Takeno Y, Kurachi K, Yamada M, Higashi Y, Kimura H, Hamada A, Nishigaki F, Tamura K.   +16 more
europepmc   +1 more source

A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis. [PDF]

Ther Adv Neurol Disord
Selmaj K, Gold R, Selmaj I, Mycko MP.
europepmc   +1 more source

SNAP-Tag-Based Antibody-Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer Treatment. [PDF]

ACS Omega
Zhang C, Sheng W, Mohiuddin TM, Al-Rawe M, Schmitz R, Niebert M, Zeppernick F, Meinhold-Heerlein I, Hussain AF.   +8 more
europepmc   +1 more source

Development of a flow cytometry method to measure antidrug antibodies against CAR T cells. [PDF]

Immunohorizons
Day G, Sánchez-Martín FJ, Seavers L, Cadwallader K, Morgado-García S.   +4 more
europepmc   +1 more source

Anisotropic gold nanochains with dual-ligand interfaces for theranostic immune activation. [PDF]

RSC Adv
Yang C, Son YJ, Jin S, Park Y, Jung YM, Kang SG, Yoo HS.   +6 more
europepmc   +1 more source